All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: Cell line-30696772

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30696772	A517V	gp41	Env	Cell line	D G R	View
2	30696772	E647G	gp41	Env	Cell line	D G R	View
3	30696772	E662G	gp41	Env	Cell line	D G R	View
4	30696772	H643Q	gp41	Env	Cell line	D G R	View
5	30696772	I515F	gp41	Env	Cell line	D G R	View
6	30696772	I515T	gp41	Env	Cell line	D G R	View
7	30696772	K588E	gp41	Env	Cell line	D G R	View
8	30696772	K588N	gp41	Env	Cell line	D G R	View
9	30696772	K601E	gp41	Env	Cell line	D G R	View
10	30696772	K665Q	gp41	Env	Cell line	D G R	View
11	30696772	L523F	gp41	Env	Cell line	D G R	View
12	30696772	L544S	gp41	Env	Cell line	D G R	View
13	30696772	N611D	gp41	Env	Cell line	D G R	View
14	30696772	N624D	gp41	Env	Cell line	D G R	View
15	30696772	N636S	gp41	Env	Cell line	D G R	View
16	30696772	N637K	gp41	Env	Cell line	D G R	View
17	30696772	Q577R	gp41	Env	Cell line	D G R	View
18	30696772	Q590E	gp41	Env	Cell line	D G R	View
19	30696772	T605N	gp41	Env	Cell line	D G R	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.